Literature DB >> 28713156

Discovery of a novel calcium-sensitive fluorescent probe for α-ketoglutarate.

Lin-Lin Gan1,2, Lin-Hai Chen1,2, Fa-Jun Nan1,2.   

Abstract

α-Ketoglutarate (α-KG), a pivotal metabolite in energy metabolism, has been implicated in nonalcoholic fatty liver disease (NAFLD) and several cancers. It is recently proposed that plasma α-KG is a surrogate biomarker of NAFLD. Here, we report the development of a novel "turn-on" chemosensor for α-KG that contains a coumarin moiety as a fluorophore. Using benzothiazole-coumarin (BTC) as inspiration, we designed a probe for calcium ion recognition that possesses a unique fluorophore compared with previously reported probes for α-KG measurement. This chemosensor is based on the specific Schiff base reaction and the calcium ion recognition property of the widely used calcium indicator BTC. The probe was synthesized, and a series of parallel experiments were conducted to optimize the chemical recognition process. Compared to the initial weak fluorescence, a remarkable 7.6-fold enhancement in fluorescence intensity (I/I0 at 495 nm) was observed for the conditions in which the probe (1 μmol/L), α-KG (50 μmol/L), and Ca2+ (100 μmol/L) were incubated at 30 °C in EtOH. The probe displayed good selectivity for α-KG even in an environment with an abundance of amino acids and other interfering species such as glutaric acid. We determined that the quantitative detection range of α-KG in EtOH was between 5 and 50 μmol/L. Finally, probe in serum loaded with α-KG (10 mmol/L) showed a 7.4-fold fluorescence enhancement. In summary, a novel probe for detecting the biomarker α-KG through a typical Schiff base reaction has been discovered. With further optimization, this probe may be a good alternative for detecting the physiological metabolite α-KG.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28713156      PMCID: PMC5719158          DOI: 10.1038/aps.2017.75

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  19 in total

1.  Dark Hydrazone Fluorescence Labeling Agents Enable Imaging of Cellular Aldehydic Load.

Authors:  Lik Hang Yuen; Nivedita S Saxena; Hyun Shin Park; Kenneth Weinberg; Eric T Kool
Journal:  ACS Chem Biol       Date:  2016-06-24       Impact factor: 5.100

2.  A simple naphthalene-based fluorescent probe for high selective detection of formaldehyde in toffees and HeLa cells via aza-Cope reaction.

Authors:  Junchao Xu; Yue Zhang; Lintao Zeng; Jinbiao Liu; Joseph M Kinsella; Ruilong Sheng
Journal:  Talanta       Date:  2016-08-02       Impact factor: 6.057

3.  Toward a biomarker of oxidative stress: a fluorescent probe for exogenous and endogenous malondialdehyde in living cells.

Authors:  Jin Chen; Lingyu Zeng; Tian Xia; Shuang Li; Tengfei Yan; Song Wu; Guofu Qiu; Zhihong Liu
Journal:  Anal Chem       Date:  2015-07-28       Impact factor: 6.986

4.  Cancer-associated IDH1 mutations produce 2-hydroxyglutarate.

Authors:  Lenny Dang; David W White; Stefan Gross; Bryson D Bennett; Mark A Bittinger; Edward M Driggers; Valeria R Fantin; Hyun Gyung Jang; Shengfang Jin; Marie C Keenan; Kevin M Marks; Robert M Prins; Patrick S Ward; Katharine E Yen; Linda M Liau; Joshua D Rabinowitz; Lewis C Cantley; Craig B Thompson; Matthew G Vander Heiden; Shinsan M Su
Journal:  Nature       Date:  2009-12-10       Impact factor: 49.962

5.  Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha.

Authors:  Shimin Zhao; Yan Lin; Wei Xu; Wenqing Jiang; Zhengyu Zha; Pu Wang; Wei Yu; Zhiqiang Li; Lingling Gong; Yingjie Peng; Jianping Ding; Qunying Lei; Kun-Liang Guan; Yue Xiong
Journal:  Science       Date:  2009-04-10       Impact factor: 47.728

6.  Metabolomic analysis of simvastatin and fenofibrate intervention in high-lipid diet-induced hyperlipidemia rats.

Authors:  Qiu-yu Xu; Yin-hui Liu; Qi Zhang; Bo Ma; Zhen-dong Yang; Lei Liu; Di Yao; Guang-bo Cui; Jing-jing Sun; Zi-mei Wu
Journal:  Acta Pharmacol Sin       Date:  2014-09-15       Impact factor: 6.150

7.  IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype.

Authors:  Sevin Turcan; Daniel Rohle; Anuj Goenka; Logan A Walsh; Fang Fang; Emrullah Yilmaz; Carl Campos; Armida W M Fabius; Chao Lu; Patrick S Ward; Craig B Thompson; Andrew Kaufman; Olga Guryanova; Ross Levine; Adriana Heguy; Agnes Viale; Luc G T Morris; Jason T Huse; Ingo K Mellinghoff; Timothy A Chan
Journal:  Nature       Date:  2012-02-15       Impact factor: 69.504

8.  The mechanisms of IDH mutations in tumorigenesis.

Authors:  Dan Ye; Yue Xiong; Kun-Liang Guan
Journal:  Cell Res       Date:  2012-03-27       Impact factor: 46.297

9.  NADP(+)-IDH Mutations Promote Hypersuccinylation that Impairs Mitochondria Respiration and Induces Apoptosis Resistance.

Authors:  Feng Li; Xiadi He; Dingwei Ye; Yan Lin; Hongxiu Yu; Cuifang Yao; Lei Huang; Jianong Zhang; Fang Wang; Sha Xu; Xiaohui Wu; Lixia Liu; Chen Yang; Jiaqi Shi; Xiaoyang He; Jie Liu; Yuanyuan Qu; Fushen Guo; Jianyuan Zhao; Wei Xu; Shimin Zhao
Journal:  Mol Cell       Date:  2015-11-12       Impact factor: 19.328

Review 10.  Hydrogen sulfide and translational medicine.

Authors:  Wei Guo; Ze-Yu Cheng; Yi-Zhun Zhu
Journal:  Acta Pharmacol Sin       Date:  2013-10       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.